Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.09%, DAX (0.11%), CAC40 +0.05%

Jan 14 ,2026

  • Synopsis

    • European equity markets are set for a mixed open, with UK and France indicated to open higher and Germany lower. Asia equities seeing more gains Wednesday. Japan stocks extending its rally as speculation over a snap general election grows. Greater China stocks turning lower as authorities moving to raise margin finance ratio to dampened enthusiasm. South Korea and Taiwan seeing fresh gains, Australia marginally higher. India flat, Singapore a point or two lower. US futures are lower.

    • Foreign ministers of Greenland and Denmark will meet US VP Vance and US Secretary of State Rubio at the White House on Wed for talks on Greenland. Greenland PM Nielsen told a joint press conf with Danish PM Frederiksen on Tue that the island will not be owned or governed by Washington but wants a peaceful dialogue with focus on cooperation.

    • In politics, Chancellor Merz will deliver an economic policy speech and subsequently participate in a discussion with the Minister of Economic Affairs of Saxony-Anhalt, Sven Schulze, at event hosted by Halle-Dessau Chamber of Industry and Commerce, others. In UK, after MPs questions on Scotland, weekly PMQs begins at 12noon GMT, whilst committee topics include drought preparedness at 10:00 and building support for the energy transition at 15:00.

    • In central banks, BOE's Taylor speech at 8:00GMT at the National Univ. of Singapore 'Driving over the peak - or a false summit', ECB's de Guindos speech at 9:20CET at Spain Investors Day 2026 (through Thu) and BOE's Ramsden speech at 15:30GMT at King's College London 'The evolution of resolution'. Poland central bank interest rate decision. Bank of Italy releases survey on expectations for inflation and growth. The 4.0% benchmark interest rate is expected to be left unchanged. Hungary central bank releases minutes of last MPC meeting.

    • A quiet macro front sees Finland Dec CPI on the agenda.

    • In earnings, Orion (ORNBV.FH) released guidance for FY26 and estimates annual Nubeqa net sales has potential to exceed €1B in the future. Rockwool (ROCK.B.DC) confirmed press report that Russia has taken control of the company's four factories in the country; the Russian business reported revenue and EBIT of €261M and €78M respectively in FY25. In Southern Europe, Jeronimo Martins (JMT.PL) reported preliminary Q4 revenue €9.46B vs StreetAccount €9.41B.

    • Amongst events and conferences are the Detroit Auto Show, opening press conf ahead of the International Green Week in Berlin, and International Bankers Forum hosts FUTURE EUROPE Conf 2026. Nueva Economía Fórum event (livestream) at 9:00CET with former Catalonian president Artur Mas.

  • Politics/Macro/World News

    • Europe goes all out to make a deal with Trump on Greenland - politico

    • Greenland and Denmark unite against US advances before White House talks - Guardian

    • French central bank sees fourth quarter growth of at least 0.2% - Reuters

    • US senators introduce bill to stop military from occupying Nato territories -- FT

  • Top company news

    • Earnings/updates

      • Nordics:

        • ORNBV.FH (Orion) -- guides FY26; also estimates annual Nubeqa net sales has potential to exceed €1B in the future

        • ROCK.B.DC (Rockwool) -- announces that Russia has taken control of the company's four factories in the country

        • BONEX.SS (BONESUPPORT HOLDING) -- reports prelim Q4 revenue SEK313M vs FactSet SEK320.2M [5 est, SEK309-330.8M]; guides FY26

      • Southern Europe:

        • JMT.PL (Jeronimo Martins) -- reports preliminary Q4 revenue €9.46B vs StreetAccount €9.41B (post EU close 13-Jan)

    • M&A

      • MUX.GR (Mutares) -- successfully completes sale of LiBCycle to Reverse Logistics Group by Reconomy

      • MEGP.LN (ME Group International) -- FPCI Montefiore Investment IV to place ~12.5M shares in ME Group

      • AZN.LN (AstraZeneca) -- to acquire Modella AI; financial terms undisclosed

      • NOVO.B.DC (Novo Nordisk) -- looking to buy in obesity - Bloomberg

      • RIO.AU (Rio Tinto) -- reported to have engaged multiple banks to advise on the potential acquisition of Glencore - Reuters

      • SALM.NO (Salmar) -- announces settlement of acquisition of shares in Øylaks MTB AS

      • WKP.LN (Workspace Group) -- holder Saba Capital sends letter to board

      • PRB.CN (Probe Gold) -- holders vote in favour of acquisition by Fresnillo at C$3.65/share

    • Healthcare

      • AZN.LN (AstraZeneca) -- Transcript Intelligence: AstraZeneca at J.P. Morgan Healthcare Conference

      • REGN (Regeneron) -- Trump administration appears to have ended its US trade probe into pharma - Endpoints News

      • BBIO (BridgeBio Pharma) -- NICE recommends Eidos's Beyonttra to treat wild-type or hereditary transthyretin amyloidosis with cardiomyopathy

      • BAYN.GR (Bayer AG) -- Transcript Intelligence: Bayer AG at J.P. Morgan Healthcare Conference

      • FME.GR (Fresenius Medical Care) -- Transcript Intelligence: Fresenius Medical Care at J.P. Morgan Healthcare Conference

      • GMAB.DC (Genmab) -- Transcript Intelligence: Genmab at J.P. Morgan Healthcare Conference

      • IPN.FP (Ipsen) --

        • announces FDA Breakthrough Therapy Designation for IPN60340

        • announced today the presentation of 14 across multiple neurological conditions at the TOXINS 2026 conference

      • GALD.SW (Galderma Group) --

        • FDA grants orphan drug designation to nemolizumab for systemic sclerosis

        • Galderma to present data on its neuromodulator portfolio at the TOXINS 2026 International Conference in Madrid

      • SDZ.SW (Sandoz Group) -- Transcript Intelligence: Sandoz Group at J.P. Morgan Healthcare Conference

      • 13.HK (Hutchmed) -- notes Phase III SACHI results published in The Lancet

      • ALM.SM (Almirall) -- Transcript Intelligence: Almirall at J.P. Morgan Healthcare Conference

    • Other

      • SITOWS.FH (Sitowise) -- appoints Anna Wäck as new CEO

      • SCR.FP (SCOR) -- appoints Philipp Rüede as Group CFO effective 7-Mar-26; announces changes to its Executive Committee

      • BST.IM (Banca Sistema) -- publishes 2026 SREP requirements; capital ratios well above the capital requirements

      • SAF.FP (Safran) -- announces €500M buyback for cancellation

      • EL.FP (EssilorLuxottica) -- and Meta in talks to double production of Ray-Ban glasses amid surging demand -- Bloomberg (earlier, intraday)

      • PRU.LN (Prudential) -- chair Shriti Vadera to retire from board after 28-May AGM

      • ENGI.FP (ENGIE) -- awarded its first hybrid solar and battery energy storage system project in India

      • AVOL.SW (Avolta) -- awarded Geneva Airport contract

      • BAER.SW (Julius Baer Group) -- COO Nic Dreckmann,is stepping down from his role, effective 13-Arpil

      • BG.AV (BAWAG Group) -- launches €75M share buyback

      • China said to restrict Nvidia chip usage; Microsoft outlines community-focused datacenter plan in intraday themes (13-Jan)

  • Key rating changes

    • Upgrades

      • Goldman Sachs upgrades KNIN.SW; downgrades DHL.GR, MAERSK.B.DC

      • Jefferies upgrades SCT.LN; downgrades BYIT.LN

      • UBS upgrades EMSN.SW; downgrades AUTN.SW

      • EL.FP (EssilorLuxottica) -- to buy from hold at HSBC

      • ITH.LN (Ithaca Energy) -- to neutral from sell at Goldman Sachs

      • YAR.NO (Yara International) -- to buy from hold at Deutsche Bank

    • Downgrades

      • RKT.LN (Reckitt Benckiser) -- sector perform from outperform at RBC Capital Markets

      • NDX1.GR (Nordex) -- to hold from buy at Kepler Cheuvreux

    • Initiations

      • BofA initiates CCR.LN; upgrades FEVR.LN, RBREW.DC; downgrades CCEP.NA

      • DIE.BB (D'Ieteren Group) --buy at Berenberg

  • Data

    • Nikkei +1.48% to 54341.23

    • Hang Seng +0.37% to 26947.61

    • Shanghai Composite (0.26%) to 4127.97

    • S&P futures (16.5) vs prior close of 7001.8

    • €-$ +0.0002 or +0.02% to 1.1647

    • $-¥ +0.03 or +0.02% to 159.20

    • €-¥ +0.10 or +0.05% to 185.42

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE